Placenta-associated biomarkers and pregnancy outcome in HPA-1a alloimmunization: A prospective cohort study.

Introduction: Fetal and neonatal alloimmune thrombocytopenia (FNAIT) results from parental incompatibility in human platelet antigens (HPA) and subsequent maternal sensitization. The HPA-1a epitope is also expressed on placental tissue. Chronic placental inflammation and lower birth weight is observed more often in HPA-1a alloimmunized pregnancies, suggesting a placental component in the pathophysiology of FNAIT.

What's with the boys? Lower birth weight in boys from HPA-1a alloimmunized pregnancies - New insights from a large prospective screening study in Poland.

Fetomaternal incompatibility in human platelet antigens (HPAs) can cause maternal alloimmunization, which in turn may lead to thrombocytopenia with or without intracranial hemorrhage (ICH) in the fetus or newborn. Retrospective studies suggest that boys from alloimmunized mothers may have higher risk of ICH and lower birth weight than girls. The objective of this study was to assess how maternal HPA-1a alloimmunization, sex of the neonate and birth weight relates in a large prospective cohort.

Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.

Background: Maternal alloantibodies to human platelet antigen-1a can cause severe intracranial hemorrhage in a fetus or newborn. Although never evaluated in placebo-controlled clinical trials, most Western countries use off-label weekly administration of high-dosage intravenous immunoglobulin in all pregnant women with an obstetrical history of fetal and neonatal alloimmune thrombocytopenia. In Norway, antenatal intravenous immunoglobulin is only recommended in pregnancies wherein a previous child had intracranial hemorrhage (high-risk) and is generally not given in other human platelet antigen-1a alloimmunized pregnancies (low-risk).

Permanganometric Titration for the Quantification of Purified Bis(2,4,4-trimethylpentyl)dithiophosphinic Acid in -Dodecane.

The organic soluble extractant bis(2,4,4-trimethylpentyl)dithiophosphinic acid, often called Cyanex 301 (HC301), has shown selectivity for preferentially extracting trivalent actinides over the lanthanides in the treatment of used nuclear fuel. To maintain control and efficiency of a separation process using this extractant, it is necessary to accurately know specific parameters of the system, including the concentration of HC301 in the organic phase, at any given time. Here, the ability to quickly determine the concentration of HC301 in -dodecane was tested by a one-step permanganometric titration in an organic solution using a double-beam UV-vis spectrophotometer.

Microcolumn lanthanide separation using bis-(2-ethylhexyl) phosphoric acid functionalized ordered mesoporous carbon materials.

Adjacent lanthanides are among the most challenging elements to separate, to the extent that current separations materials would benefit from transformative improvement. Ordered mesoporous carbon (OMC) materials are excellent candidates, owing to their small mesh size and uniform morphology. Herein, OMC materials were physisorbed with bis-(2-ethylhexyl) phosphoric acid (HDEHP) and sorption of Eu was investigated under static and dynamic conditions.